Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Chemicals Specialty Chemicals
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration... see more

Recent & Breaking News (NYSE:DNA)

Ginkgo Bioworks and the Ministry of Health of the Republic of Botswana Announce Plans to Develop and Implement New Biosecurity Capabilities in Botswana

PR Newswire December 20, 2022

Ginkgo Bioworks Launches Ginkgo Enzyme Services, Enabling Applications across Pharmaceuticals and Diagnostics, Food and Agriculture, and Beyond

PR Newswire December 8, 2022

Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions

PR Newswire December 2, 2022

Ginkgo Announces Public Offering of Class A Common Stock

PR Newswire November 16, 2022

Ginkgo Bioworks Announces Proposed Public Offering of Class A Common Stock

PR Newswire November 15, 2022

Ginkgo Bioworks Reports Third Quarter 2022 Financial Results

PR Newswire November 14, 2022

Lygos and Ginkgo Bioworks Announce Partnership to Optimize Production of Biobased Specialty Chemicals

PR Newswire November 11, 2022

Ginkgo Bioworks To Present New Data on High Throughput Pooled Screening Method to Discover Novel CAR-T Designs for Solid Tumors

PR Newswire November 9, 2022

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Ginkgo Bioworks Holdings, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire November 7, 2022

Ginkgo Bioworks Announces Date of Third Quarter 2022 Results Presentation

PR Newswire November 7, 2022

Ginkgo Bioworks and the Ministry of Investment of Saudi Arabia Announce Plans to Develop Biosecurity and Biotechnology Capabilities for Global Public Health

PR Newswire October 25, 2022

Bolt Threads Announces Latest Collaboration with Ginkgo Bioworks to Optimize its Mylo(TM) Material

PR Newswire October 20, 2022

Ginkgo Bioworks Completes Acquisition of Zymergen

PR Newswire October 19, 2022

IARPA, Ginkgo Bioworks and Draper Announce New Technologies to Detect Engineered DNA

PR Newswire October 17, 2022

Ginkgo Bioworks Announces Collaboration with Merck to Improve Active Pharmaceutical Ingredient Manufacturing

PR Newswire October 11, 2022

Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy

PR Newswire October 4, 2022

Ginkgo Bioworks Acquires Adaptive Laboratory Evolution Company Altar

PR Newswire October 4, 2022

ZYMERGEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zymergen - ZY

PR Newswire September 20, 2022

Renee Wegrzyn Slated to Lead New Advanced Research Projects Agency for Health

PR Newswire September 12, 2022

Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools

PR Newswire September 1, 2022